Indian biopharmaceutical company headquartered in Bengaluru, Karnataka, founded in 1978 by Kiran Mazumdar-Shaw as an enzymes business and listed on the Indian exchanges. Makes and sells small molecule active ingredients and finished formulations, biosimilar insulins and monoclonal antibodies through Biocon Biologics, which bought Viatris's biosimilars business, and provides contract research and development through Syngene International, with plants in Bengaluru, Visakhapatnam, Hyderabad, Malaysia and elsewhere.
Aucun commentaire disponible.
Laissez votre note & commentaire